PreDxion Bio
DefunctYC S17San Francisco, US · Founded 2017 · 6 employees · 5 known investors
Find your way into PreDxion Bio
Sign up to see every warm intro you have to PreDxion Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PreDxion Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PreDxion Bio develops a rapid saliva-based antigen test for detecting SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients, scalable using semiconductor fabrication processes. Its original technology, spun out of the University of Michigan, is a near real-time cytokine and biomarker detection platform for monitoring immune response in critically ill patients, including those undergoing CAR-T therapy.
Founders & leadership· Y Combinator alumni (S17)
PreDxion Bio was founded in 2017 by Walker McHugh and Timothy Cornell.
Investors · 5
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Related companies · 5
Companies working in the same space as PreDxion Bio.
Legal entities · 1
corporate structureFrequently asked questions
- What does PreDxion Bio do?
- PreDxion Bio develops a rapid saliva-based antigen test for detecting SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients, scalable using semiconductor fabrication processes. Its original technology, spun out of the University of Michigan, is a near real-time cytokine and biomarker detection platform for monitoring immune response in critically ill patients, including those undergoing CAR-T therapy.
- Who founded PreDxion Bio?
- PreDxion Bio was founded by Walker McHugh, Timothy Cornell in 2017.
- Who are PreDxion Bio's investors?
- PreDxion Bio's investors include Y Combinator, Agrolimen Ventures, Hillsven, Invest Detroit, SignalFire.
- Where is PreDxion Bio headquartered?
- PreDxion Bio is headquartered in San Francisco, US.










